• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: BIOMARKERS IN MS

sNfL a useful alternative to gadolinium

July 31, 2023  

EAN HIGHLIGHTS 2023 – WEDNESDAY, JULY 5 EDITION

July 5, 2023  

EAN HIGHLIGHTS 2023 – MONDAY, JULY 3 EDITION

July 3, 2023  

NfL – a guide to use in MS practice

May 31, 2023  

Emerging role of CHI3L1 as MS biomarker

May 2, 2023  

AAN 2023 HIGHLIGHTS – WEDNESDAY, APRIL 26

April 26, 2023  

AAN 2023 HIGHLIGHTS – TUESDAY, APRIL 25

April 25, 2023  

AAN 2023 HIGHLIGHTS – MONDAY, APRIL 24

April 24, 2023  

sNfL a biomarker of future disease activity: APLIOS

April 12, 2023  

Putting biomarkers into practice

March 8, 2023  
Previous
2
3
4
5
6
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions